Vivos Therapeutics Founder & Chief Medical Officer Releases New Book Highlighting His Groundbreaking Work
May 26, 2021 08:00 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., May 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update
May 17, 2021 16:05 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., May 17, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Schedules First Quarter 2021 Financial Results Conference Call
May 13, 2021 08:00 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., May 13, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
May 11, 2021 16:29 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., May 11, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering
May 06, 2021 21:41 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education
April 14, 2021 09:15 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 14, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics to Participate at the Emerging Growth Conference
April 12, 2021 08:00 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 12, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
March 30, 2021 08:00 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 30, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
March 25, 2021 16:05 ET | Vivos Therapeutics, Inc
Full Year Revenue Increase of 15% Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH, Colo., March 25, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the...
Vivos Therapeutics to Participate at the Benzinga Biotech Small Cap Conference
March 22, 2021 16:05 ET | Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 22, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...